Status:
COMPLETED
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)
Lead Sponsor:
Organon and Co
Conditions:
Osteoporosis, Postmenopausal
Eligibility:
FEMALE
45+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see how well alendronate and calcium as compared to calcium alone increase bone density in postmenopausal women with osteoporosis
Eligibility Criteria
Inclusion
- Inclusion Criteria :
- Patient is postmenopausal (or surgically menopausal) for at least 5 years.
- Patient must be diagnosed with osteoporosis
- Patient has spinal anatomy suitable for DEXA of the lumbar spine
- Exclusion Criteria :
- Patient is receiving or has received treatment prior to randomization which might influence bone turnover
- Patient has a history of or evidence for metabolic bone disease (other than postmenopausal bone loss)
- Patient is receiving or is expected to receive during the course of the study any medication (other than study medication) which might alter bone or calcium metabolism
Exclusion
Key Trial Info
Start Date :
April 1 1995
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
650 Patients enrolled
Trial Details
Trial ID
NCT00398606
Start Date
April 1 1995
Last Update
February 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.